UNITED THERAPEUTICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.3 USD | -0.67% |
|
+0.71% | +20.18% |
| 05-10 | United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing | MT |
| 05-08 | United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Other Biotechnology & Medical Research | -0.67% | +0.71% | +20.18% | +23.48% | +179.24% | 11.72B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- UTHR Stock
- Charts United Therapeutics Corporation
- Comparison Chart